Cargando…
Factors associated with persistent positive in HBV DNA level in patients with chronic Hepatitis B receiving entecavir treatment
INTRODUCTION: The clinical significance of persistent positive in Hepatitis B Virus (HBV) DNA level in patients receiving antiviral therapy is not well known. We investigated factors associated with persistent viremia (PV) in patients with chronic hepatitis B (CHB) given 78-week entecavir. METHODS:...
Autores principales: | Li, Jun, Dong, Xiao-Qin, Cao, Li-Hua, Zhang, Zhan-Qing, Zhao, Wei-Feng, Shang, Qing-Hua, Zhang, Da-Zhi, Ma, An-Lin, Xie, Qing, Gui, Hong-Lian, Zhang, Guo, Liu, Ying-Xia, Shang, Jia, Xie, Shi-Bin, Liu, Yi-Qi, Zhang, Chi, Wang, Gui-Qiang, Zhao, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311917/ https://www.ncbi.nlm.nih.gov/pubmed/37396307 http://dx.doi.org/10.3389/fcimb.2023.1151899 |
Ejemplares similares
-
Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scores
por: Huang, Yan, et al.
Publicado: (2022) -
An-Luo-Hua-Xian Pill Improves the Regression of Liver Fibrosis in Chronic Hepatitis B Patients Treated with Entecavir
por: Liu, Yi-Qi, et al.
Publicado: (2023) -
The Hepatitis B Surface Antigen Binding Protein: An Immunoglobulin G Constant Region-Like Protein That Interacts With HBV Envelop Proteins and Mediates HBV Entry
por: Sun, Yeping, et al.
Publicado: (2018) -
Histological Outcome of Fuzheng Huayu plus Entecavir Combination Therapy in Chronic Hepatitis B Patients with Significant Liver Fibrosis
por: Gui, Hong-Lian, et al.
Publicado: (2020) -
Oral Microbiota Perturbations Are Linked to High Risk for Rheumatoid Arthritis
por: Tong, Yanli, et al.
Publicado: (2020)